MARAGANORE JOHN — SEC insider filings

SEC reporting owner CIK 1180432. 34 insider filings on record with FilingPulse; latest filed 2026-10-22.

Transaction summary — filings shown

Covers all 34 filings on record, filed 2020-08-21 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ALNYLAM PHARMACEUTICALS, INC. (ALNY)Chief Executive Officer, Director10—35 legs · 205,445 sh · $31,116,71032
Rapport Therapeutics, Inc. (RAPP)Director32 legs · 9,411 sh · $248,891—2
AGIOS PHARMACEUTICALS, INC. (AGIO)Director4——9
Beam Therapeutics Inc. (BEAM)Director6——6
Hemab Therapeutics Holdings, Inc. (COAG)Director1——5
Kymera Therapeutics, Inc. (KYMR)Director5——5
CITY THERAPEUTICS, INC. (CTY)Director2——4
PROKIDNEY CORP. (PROK)Director2——3
TAKEDA PHARMACEUTICAL CO LTD (TAK)Director1——3

Insider filings — MARAGANORE JOHN

FiledFormIssuerReported transactionsSource
2026-10-224Rapport Therapeutics, Inc. (RAPP)Purchase (P): 8,239 @ $26.38 · Purchase (P): 1,172 @ $26.92EDGAR
2026-10-194CITY THERAPEUTICS, INC. (CTY)Conversion (C): 610,759 · Grant/award (A): 22,649 (derivative) @ $0 · Conversion (C): 500,000 (derivative) @ $0 · Conversion (C): 56,095 (derivative) @ $0EDGAR
2026-10-153CITY THERAPEUTICS, INC. (CTY)Holdings only — no transactions reportedEDGAR
2026-07-064TAKEDA PHARMACEUTICAL CO LTD (TAK)Grant/award (A): 3,800 @ $0 · Disposition to issuer (D): 1,152 (derivative) @ $4,931.20 · Grant/award (A): 1,319 (derivative) @ $0EDGAR
2026-06-254Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 6,068 (derivative) @ $0EDGAR
2026-06-104Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 15,200 (derivative) @ $0EDGAR
2026-06-054Beam Therapeutics Inc. (BEAM)Grant/award (A): 19,676 (derivative) @ $0EDGAR
2026-05-044Hemab Therapeutics Holdings, Inc. (COAG)Conversion (C): 17,974 · Conversion (C): 17,974 · Grant/award (A): 107,338 (derivative) @ $0 · Conversion (C): 817 (derivative) @ $0 · Conversion (C): 817 (derivative) @ $0EDGAR
2025-06-264Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-06-184Rapport Therapeutics, Inc. (RAPP)Grant/award (A): 21,850 (derivative) @ $0EDGAR
2025-06-064Beam Therapeutics Inc. (BEAM)Grant/award (A): 33,662 (derivative) @ $0EDGAR
2024-06-204Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2024-06-074Beam Therapeutics Inc. (BEAM)Grant/award (A): 23,114 (derivative) @ $0EDGAR
2023-07-034PROKIDNEY CORP. (PROK)Grant/award (A): 48,128 (derivative) @ $0EDGAR
2023-06-204Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2023-06-084Beam Therapeutics Inc. (BEAM)Grant/award (A): 16,532 (derivative) @ $0EDGAR
2022-09-024Beam Therapeutics Inc. (BEAM)Grant/award (A): 10,391 (derivative) @ $0EDGAR
2022-07-134PROKIDNEY CORP. (PROK)Grant/award (A): 614,013 (derivative) @ $0 · Grant/award (A): 614,013 (derivative) @ $0EDGAR
2022-06-234AGIOS PHARMACEUTICALS, INC. (AGIO)Grant/award (A): 4,975 (derivative) @ $0 · Grant/award (A): 29,307 (derivative) @ $0EDGAR
2022-05-244AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 1,585 @ $0 · Option exercise (M): 1,585 (derivative) @ $0EDGAR
2022-01-194Kymera Therapeutics, Inc. (KYMR)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2021-12-234ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 14,167 @ $0 · Tax withholding (F): 6,315 @ $189.13 · Tax withholding (F): 2 @ $190.50 · Tax withholding (F): 319 @ $186.02EDGAR
2021-12-144ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 1,036 @ $96.45 · Option exercise (M): 1,124 @ $88.95 · Option exercise (M): 839 @ $119.13 · Option exercise (M): 2,368 @ $42.22 · Option exercise (M): 2,368 (derivative) @ $0 · Option exercise (M): 1,124 (derivative) @ $0 · +2 moreEDGAR
2021-11-124ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 33,978 @ $7.10 · Sale (S): 10,365 @ $170.36 · Sale (S): 7,742 @ $171.35 · Sale (S): 14,518 @ $172.22 · Sale (S): 683 @ $173.25 · Sale (S): 670 @ $174.34 · +1 moreEDGAR
2021-11-084Beam Therapeutics Inc. (BEAM)Grant/award (A): 13,133 (derivative) @ $0EDGAR
2021-08-164ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 33,979 @ $7.10 · Sale (S): 2,441 @ $198.02 · Sale (S): 4,160 @ $198.93 · Sale (S): 23,336 @ $199.92 · Sale (S): 3,828 @ $200.84 · Sale (S): 214 @ $201.55 · +1 moreEDGAR
2021-06-024AGIOS PHARMACEUTICALS, INC. (AGIO)Gift (G): 3,415 @ $0 · Option exercise (M): 1,686 @ $0 · Option exercise (M): 1,686 (derivative) @ $0EDGAR
2021-05-244AGIOS PHARMACEUTICALS, INC. (AGIO)Grant/award (A): 1,585 (derivative) @ $0 · Grant/award (A): 8,888 (derivative) @ $0EDGAR
2021-05-174ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 33,979 @ $7.10 · Sale (S): 3,015 @ $128.30 · Sale (S): 4,512 @ $129.32 · Sale (S): 9,121 @ $130.34 · Sale (S): 11,203 @ $131.18 · Sale (S): 3,481 @ $132.32 · +3 moreEDGAR
2021-04-214ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 16,236 @ $0 · Tax withholding (F): 7,237 @ $131.75 · Tax withholding (F): 270 @ $134.62EDGAR
2021-02-264ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 33,979 @ $7.10 · Sale (S): 1,001 @ $143.88 · Sale (S): 6,129 @ $145.15 · Sale (S): 9,376 @ $146.13 · Sale (S): 6,097 @ $146.98 · Sale (S): 4,375 @ $148 · +8 moreEDGAR
2021-02-164ALNYLAM PHARMACEUTICALS, INC. (ALNY)Grant/award (A): 14,166 @ $0 · Tax withholding (F): 5,412 @ $156 · Tax withholding (F): 307 @ $151.94 · Grant/award (A): 17,504 (derivative) @ $0EDGAR
2020-11-204ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 34,765 @ $9.14 · Sale (S): 18,987 @ $123.55 · Sale (S): 5,489 @ $124.49 · Sale (S): 10,187 @ $125.35 · Sale (S): 102 @ $126.62 · Option exercise (M): 34,765 (derivative) @ $0EDGAR
2020-08-214ALNYLAM PHARMACEUTICALS, INC. (ALNY)Option exercise (M): 34,765 @ $9.14 · Sale (S): 4,775 @ $135.09 · Sale (S): 21,448 @ $136.07 · Sale (S): 8,542 @ $136.86 · Option exercise (M): 34,765 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1180432 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs